CLS Investments »

Capricor Therapeutics shares owned by CLS Investments

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by CLS Investments from 13F filings

Historical chart of CLS Investments investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by CLS Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by CLS Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $239k 8.3k 28.86

More positions owned by CLS Investments

Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Ishares Tr Core S&p500 Etf (IVV)
Northern Lts Fd Tr Iv Main Buywrite (BUYW)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Advisors Inner Circle Fd Ii 3edge Dynamic Fi (EDGF)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Value Etf (VTV)

View all positions for CLS Investments

Top funds holding Capricor Therapeutics

BlackRock
Susquehanna International
Vanguard Group
Point72 Asset Management
Suvretta Capital Management
Tang Capital Management
Citadel Advisors
Geode Capital Management
Caption Management
State Street Corporation
Darwin Global Management
Diadema Partners
Soleus Capital Management
J. Goldman & Co
Ikarian Capital

View all funds holding Capricor Therapeutics